BEIJING -- Ustar, a Chinese point of care (POC) startup that designs molecular diagnostic systems, has raised about 300 million yuan ($2.6 million) in a Series E+ funding round.
36Kr/KrASIA
Chinese startup develops PCR testing equipment for household use
Product gives accurate COVID-19 test results without special training
Ustar has developed PCR testing equipment for household use. (Phot courtesy of the company)
Read Next
Latest on 36Kr/KrASIA
